March 10, 2022 Synthetic Biologics to Host Conference Call and Webcast to Discuss 2021 Year End Operational Highlights and Financial Results
February 8, 2022 Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDA
January 26, 2022 Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022
